The objective of this study is to determine the effect of intravenous ( i.v. ) or oral N-acetylcysteine ( NAC ) in preventing contrast-induced nephropathy ( CIN ) in patients with moderate-to-severe renal insufficiency undergoing intra-arterial interventions .